Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00966368 · ClinicalTrials.gov registry record · Phase 1
Comparison of Two NN1250 Formulations in Healthy Volunteers
A Phase 1 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT00966368 is a Phase 1 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 27 participants.
The verdict
NCT00966368, a Phase 1 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
This trial was conducted in North America. The aim of this clinical trial was to investigate if two formulations of NN1250 (insulin degludec) have the same level of drug exposure to the body.
Interventions
- DRUG insulin degludec
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00966368
The ClinicalTrials.gov registry entry for NCT00966368 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which insulin degludec is the first listed.
NCT00966368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00966368 about?
NCT00966368 is a clinical study titled "Comparison of Two NN1250 Formulations in Healthy Volunteers". This trial was conducted in North America. The aim of this clinical trial was to investigate if two formulations of NN1250 (insulin degludec) have the same level of drug exposure to the body.
What is the current status of trial NCT00966368?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2009-08. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00966368?
The interventions under investigation include: insulin degludec (DRUG).
Who is sponsoring clinical trial NCT00966368?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.